CD8A and cancer: First, to investigate whether CTL and PD-L1 show different associations with clinical outcome, we estimated the CTL level using the expression level of CD8A, and evaluated the prognostic value of CD8A and PD-L1 expression in 15 solid TCGA cancer types using Cox proportional hazard analysis (Cox-PH).